Altimmune (ALT) PT Raised to $35 at Jefferies Ahead of Readouts on Potential Mega-Blockbuster Obesity Drug
Tweet Send to a Friend
Jefferies analyst Roger Song raised the price target on Altimmune (NASDAQ: ALT) to $35.00 (from $30.00) while maintaining a Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
